Fiona Marshall is a British pharmacologist and biotech-founder who serves as President of Biomedical Research at Novartis. She founded Heptares Therapeutics, a biopharmaceutical company, and previously held the role of Chief Scientific Officer there. Heptares Therapeutics was later acquired by the Japanese biopharmaceutical company Sosei, where Marshall served as Vice President.